Julie Berg Schmidt

Julie Berg Schmidt

Auto-generated profile, based on publicly available information

Julie Berg Schmidt

Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
JSJulie Berg Schmidt
Julie Berg Schmidt
NGNikolaj Ture Gregersen
Nikolaj Ture Gregersen
SPSue D. Pedersen
Sue D. Pedersen
JAJohanne L. Arentoft
Johanne L. Arentoft
CRChristian Ritz
Christian Ritz
ASAnders Sjödin
Anders Sjödin
Our aim was to examine the effects of GLP-1 and PYY3–36, separately and in combination, on energy intake, energy expenditure, appetite sensations, glucose and fat metabolism, ghrelin, and vital signs in healthy overweight men. Twenty-five healthy male subjects participated in this randomized, double-blinded, placebo-controlled, four-arm crossover study (BMI 29 ± 3 kg/m2, age 33 ± 9 yr). On separate days they received a 150-min intravenous infusion of 1) 0.8 pmol·kg−1·min−1 PYY3–36, 2) 1.0 pmol·kg−1·min−1 GLP-1, 3) GLP-1 + PYY3–36, or 4) placebo. Ad libitum energy intake was assessed during the final 30 min. Measurements of appetite sensations, energy expenditure and fat oxidation, vital signs, and blood variables were collected throughout the infusion period. No effect on energy intake was found after monoinfusions of PYY3–36 (−4.2 ± 4.8%, P = 0.8) or GLP-1 (−3.0 ± 4.5%, P = 0.9). However, the coinfusion reduced energy intake compared with placebo (−30.4 ± 6.5%, P < 0.0001) and more than the sum of the monoinfusions ( P < 0.001), demonstrating a synergistic effect. Coinfusion slightly increased sensation of nausea ( P < 0.05), but this effect could not explain the effect on energy intake. A decrease in plasma ghrelin was found after all treatments compared with placebo (all P < 0.05); however, infusions of GLP-1 + PYY3–36 resulted in an additional decrease compared with the monoinfusions (both P < 0.01). We conclude that coinfusion of GLP-1 and PYY3–36 exerted a synergistic effect on energy intake. The satiating effect of the meal was enhanced by GLP-1 and PYY3–36 in combination compared with placebo. Coinfusion was accompanied by slightly increased nausea and a decrease in plasma ghrelin, but neither of these factors could explain the reduction in energy intake.

14 April 2017 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
MNMette S Nielsen
Mette S Nielsen
BCBodil J. Christensen
Bodil J. Christensen
CRChristian Ritz
Christian Ritz
SRSimone Rasmussen
Simone Rasmussen
THThea Toft Hansen
Thea Toft Hansen
JSJulie B. Schmidt
Julie B. Schmidt

23 April 2020 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
MNMette S Nielsen
Mette S Nielsen
BCBodil Just Christensen
Bodil Just Christensen
JSJulie Berg Schmidt
Julie Berg Schmidt
LTLouise Tækker
Louise Tækker
LHLotte Holm
Lotte Holm
ASAnders Mikael Sjödin
Anders Mikael Sjödin

21 June 2019 in Current Obesity Reports
Verified
Journal Article
Closed access
PDF file
MNMette S Nielsen
Mette S Nielsen
JSJulie B. Schmidt
Julie B. Schmidt
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux
ASAnders Mikael Sjödin
Anders Mikael Sjödin

1 June 2018 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
BCBodil Just Christensen
Bodil Just Christensen
JSJulie Berg Schmidt
Julie Berg Schmidt
MNMette S Nielsen
Mette S Nielsen
LTLouise Tækker
Louise Tækker
LHLotte Holm
Lotte Holm
ASAnders Mikael Sjödin
Anders Mikael Sjödin
Despite substantial research efforts, the mechanisms proposed to explain weight loss after gastric bypass (RYGB) and sleeve gastrectomy (SL) do not explain the large individual variation seen after these treatments. A complex set of factors are involved in the onset and development of obesity and these may also be relevant for the understanding of why success with treatments vary considerably between individuals. This calls for explanatory models that take into account not only biological determinants but also behavioral, affective and contextual factors. In this prospective study, we recruited 47 women and 8 men, aged 25-56 years old, with a BMI of 45.8 ± 7.1 kg/m2 from the waiting list for RYGB and SL at Køge hospital, Denmark. Pre-surgery and 1.5, 6 and 18 months after surgery we assessed various endpoints spanning multiple domains. Endpoints were selected on basis of previous studies and include: physiological measures: anthropometrics, vital signs, biochemical measures and appetite hormones, genetics, gut microbiota, appetite sensation, food and taste preferences, neural sensitivity, sensory perception and movement behaviors; psychological measures: general psychiatric symptom-load, depression, eating disorders, ADHD, personality disorder, impulsivity, emotion regulation, attachment pattern, general self-efficacy, alexithymia, internalization of weight bias, addiction, quality of life and trauma; and sociological and anthropological measures: sociodemographic measures, eating behavior, weight control practices and psycho-social factors.Joining these many endpoints and methodologies from different scientific disciplines and creating a multi-dimensional predictive model has not previously been attempted. Data on the primary endpoint are expected to be published in 2018. Clinicaltrials. gov ID NCT02070081.

30 March 2021 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
MNMette S Nielsen
Mette S Nielsen
BCBodil Just Christensen
Bodil Just Christensen
CRChristian Ritz
Christian Ritz
LHLotte Holm
Lotte Holm
SLSusanne Lunn
Susanne Lunn
ASAnders Mikael Sjödin
Anders Mikael Sjödin